CDC Vaccine Advisory Panel Purged
On June 9, 2025, U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. fired all 17 members of the U.S. Centers for Disease Control and Prevention’s (CDC) committee that makes national vaccine policy—the Advisory Committee on Immunization Practices (ACIP). “A clean sweep is necessary to reestablish public confidence in vaccine science,” Secretary Kennedy […]
FDA Approves Novavax’s COVID-19 Vaccine With Restrictions
On May 16, 2025, the U.S. Food and Drug Administration (FDA) approved licensure of Novavax, Inc.’s Nuvaxovid protein-based COVID-19 vaccine, which has been available in the United States under Emergency Use Authorization (EUA) since July 2022.1 The decision for a full licensure was postponed while the new agency leadership under the current administration conducted a […]
Influenza-COVID Combo Vaccine Trial Halted Over Safety Concerns
The U.S. Food and Drug Administration (FDA) has put a hold on Novavax’s COVID-influenza combination vaccine and standalone influenza vaccines being tested in clinical trials after a participant reported nerve damage following receipt of the experimental vaccine in January 2024.1 Reported symptoms were diagnosed as motor neuropathy, a disease process that can be acquired, hereditary […]
Novavax to Receive $350 Million for Cancelled COVID Vaccine Orders in Canada
According to a securities filing with the U.S. Securities and Exchange Commission (SEC) by Novavax Inc. of Gaithersburg, Maryland on June 30, 2023, the government of Canada will pay the company $349.6 million to settle the forfeiting of doses of its Nuvaxovid recombinant protein COVID-19 vaccine previously ordered and scheduled for delivery.1 2 Nuvaxvoid was […]
CDC Adds COVID Shots to Recommended Vaccine Schedules for Children and Adults
The U.S. Centers for Disease Control and Prevention (CDC) has updated recommended vaccine schedules for children, adolescents and adults to include the COVID-19 biologics. The move is consistent with recommendations made by the agency’s Advisory Committee on Vaccine Practices (ACIP) in October 2022.1 2 3 4 5 The update of the recommended vaccination schedules was […]
Government Buys 1.5 Million More Doses of Novavax’s COVID Vaccine
Biotechnology company Novavax announced that it has made a modification to an existing contract with the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DoD) to provide up to 1.5 million more doses of its Nuvaxovid COVID-19 vaccine (also known as “NVX-CoV2373” and “Covovax”), in addition to the 3.2 million […]